Delivery Order SPE2DB24D2100-SPE2DB25FBFTD
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,031.20 to AmerisourceBergen Drug Corp for Dexcom G7 sensors on August 8, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a $1,635.88 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Dexcom G7 sensors, with an ultimate completion date of July 30, 2025. This non-set-aside competitive award was issued on July 29, 2025, with performance conducted at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $3,120.37 to AmerisourceBergen Drug Corp for Dexcom G7 sensors on August 8, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price delivery order represents a non-competitive award issued under a larger indefinite delivery contract (IDC) vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $1,031.20 to AmerisourceBergen Drug Corp for Dexcom G7 sensors on July 30, 2025, with completion scheduled for July 31, 2025. This firm fixed price contract represents a non-competitive, non-set-aside award for continuous glucose monitoring devices to support federal medical supply needs. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $2,062.40 to AmerisourceBergen Drug Corp for Dexcom G7 sensors on August 1, 2025, with an ultimate completion date of August 4, 2025. This firm fixed price, non-competitive delivery order is being performed at the vendor's corporate office in Conshohocken, Pennsylvania. The award represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX...
- The Defense Logistics Agency awarded a delivery order valued at $1,036.08 to AmerisourceBergen Drug Corp for Dexcom G7 sensors, with an ultimate completion date of August 8, 2025. This firm fixed-price contract, issued on August 7, 2025, is a non-set-aside award issued under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical (SPE2DX). The sensors will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, which serves as...
- The Defense Logistics Agency awarded a delivery order valued at $3,221.99 to AmerisourceBergen Drug Corp for Dexcom G7 sensors on August 4, 2025, with completion scheduled for August 5, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026. The award was competitively awarded with no set-aside designation...
- The Defense Logistics Agency awarded a $10,283.29 delivery order to AmerisourceBergen Drug Corp for Dexcom G7 sensors on July 21, 2025, with an ultimate completion date of July 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor's corporate office located in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Dexcom G7 continuous glucose monitoring sensors, valued at $3,093.60. This is a firm fixed-price delivery order with an ultimate completion date of August 5, 2025, and represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical (SPE2DX), valued at $999.999...
- The Defense Logistics Agency awarded a $9,922.90 delivery order to AmerisourceBergen Drug Corp for Dexcom G7 sensors on July 21, 2025, with completion targeted for July 22, 2025. This non-set-aside contract employs firm fixed pricing and represents a direct fulfillment of medical supply needs through the company's existing indefinite delivery contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical...
- SPE2DB24D2100Indefinite Delivery Contract
- SPE2DB24D2100-SPE2DB25FBFTDDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,146.43 to AmerisourceBergen Drug Corp for Dexcom G7 sensors on August 8, 2025, with completion scheduled for August 11, 2025. This firm fixed-price delivery order represents a competitively awarded, non-set-aside procurement fulfilled by AmerisourceBergen's Corporate Office located in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime contract vehicle designated SPE2DX and extending through December 2026 that enables the company to supply pharmaceutical products and medical devices globally to support military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical federal medical procurement vendor for the Defense Logistics Agency's medical supply chain. The company's portfolio includes delivery orders for a comprehensive range of pharmaceutical products and medical supplies supporting military and veteran healthcare systems. The Dexcom G7 sensors procured under this delivery order represent specialized medical devices used for continuous glucose monitoring, consistent with AmerisourceBergen's demonstrated capability to fulfill federal requirements for diabetes management and other therapeutic medical commodities across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 8/8/25 |